Y. J. Bing et al. / Tetrahedron Letters 45 (2004) 6361–6363
6363
dry pyridine was added dropwise into the mixture, and
refluxed for three days. The crude product was concen-
trated under reduced pressure leaving a red residue. The
desired product was obtained by sol–gel column chroma-
tography using chloroform/hex (9:1) as the eluent.
6-(5-(4-N,N0-Diphenylaminophenyl)-1,3,4-oxadiazol-2-yl)
quinoxalino[2,3-f] phenanthroline (9): Yellow needle; mp
300ꢁC (DSC); 1H NMR (270MHz) d (ppm) (CDCl3) 9.64
(d, J=8.1Hz, 2H), 9.30 (s, 2H), 9.00 (s, 1H), 8.68 (d,
J=8.1Hz, 1H), 8.48 (d, J=8.1Hz, 1H), 8.02–8.07 (m, 2H),
7.80–7.85 (m, 2H), 7.30–7.39 (t, J=8.1Hz, 4H), 7.12–7.19
(m, 8H); MS (FAB): 594 (M++1). Anal. Calcd for
C38H23N7O C: 76.88%, H: 3.90%, N: 16.52%. Found C:
76.40%, H: 3.90%, N: 16.21%.
have different light-emitting characteristics but are both
functional charge transporting materials. We are cur-
rently exploring the photo and electroluminescent prop-
erties of these two compounds in OLEDs fabricated
from traditional vacuum deposition method. Further
studies for the two compounds to be used as metal coor-
dination ligand for multifunctional molecular materials
are under investigation.
Acknowledgements
This work is supported by a research grant from the re-
search grant council of the Hong Kong SAR Govern-
ment (grant number: HKBU 2037/02P) and from the
Scientific and technical project of Guangdong province
(B10502).
8. Krebs, F. C.; Spanggaard, H. J. Org. Chem. 2002, 7,
7185–7192.
9. 2-(4-N,N0-Diphenylaminephenyl)-5-(4-formalphenyl)-1,3,
1
4-oxadiazole (12). H NMR (270MHz) d (ppm) (CDCl3)
10.1 (s, 1H), 8.30 (d, J=8.1Hz, 2H), 8.04 (d, J=2.7Hz,
2H), 8.02–7.92 (m, 2H), 7.36–7.30 (m, 4H), 7.19–7.09 (m,
8H). MS (FAB): 418 (M++1).
10. 2-(4-(5-(4-N,N0-Diphenylaminophenyl)-1,3,4-oxadiazol-2-
yl)phenyl)imidazo[4,5-f] phenanthroline (13). 1H NMR
(270MHz) d (ppm) (DMSO-d6) 9.05 (dd, J=2.7, 5.4Hz,
2H), 8.99 (d, J=8.1Hz, 2H), 8.54 (d, J=8.1Hz, 2H), 8.32
(d, J=8.1Hz, 2H), 7.99 (d, J=8.1Hz, 2H), 7.89 (s, 2H),
7.40 (t, J=8.1Hz, 4H), 7.21–7.15 (m, 6H), 7.03 (d,
J=8.1Hz, 2H), 14.05 (N–H). MS (FAB): 608 (M++1).
11. 1-Ethyl-2-(4-(5-(4-N,N0-diphenylaminophenyl)-1,3,4-oxa-
diazol-2-yl)phenyl)imidazo[4,5-f] phenanthroline (14). 1H
NMR (270MHz) d (ppm) (CDCl3) 9.18 (dd, J=2.7,
5.4Hz, 2H), 9.09 (dd, J=2.7, 5.4Hz, 1H), 8.6 (d,
J=8.1Hz, 1H), 8.3 (d, J=5.4Hz, 2H), 8.01–7.93 (m,
4H), 7.75 (dd, J=5.4, 2.7Hz, 2H), 7.37–7.31 (m,4H), 7.20–
7.11 (m, 8H), 4.73 (dd, J=5.4, 2.7Hz, 2H), 1.67 (t,
J=8.1Hz, 5.4Hz, 3H). MS (FAB): 636 (M++1). Anal.
Calcd for C41H29N7OÆH2O, C: 75.33%, H: 4.78%, N:
15.00%. Found C: 74.87%, H: 4.96%, N: 14.78%.
12. Luminescence quantum yields were determined relative to
a reference solution of quinine sulfate in 1N sulfuric acid
(U=0.546) and corrected for the refractive index of the
solvent.
References and notes
1. Yasuda, T.; Yamaguchi, I.; Yamamoto, T. Adv. Mater.
2003, 15, 293–296.
2. Gong, X.; Ng, P. K.; Chan, W. K. Adv. Mater. 1998, 16,
1337–1340.
3. Meyer, M.; Kersting, B.; Powers, R. E.; Raymond, K. N.
Inorg. Chem. 1997, 36, 5179–5191.
4. Williams, A. F.; Piguet, C.; Bernardinelli, G. Angew.
Chem., Int. Ed. Engl. 1991, 30, 1490–1492.
5. Yamada, M.; Tanaka, Y.; Yoshimoto, Y.; Kuroda, S.;
Shimao, I. Bull. Chem. Soc. Jpn. 1992, 65, 1006–1011.
6. Tamoto, N.; Adachi, C.; Nagai, K. Chem. Mater. 1997, 9,
1077–1085.
7. General procedures for the synthesis of Compounds 8 and
9. To dipyrido(3,2-a,20,30-c)phenazine-8-carboxylic acid
(3.28g, 10mmol) was added thionyl chloride (60mL) and
the mixture was refluxed for 24h. The solution was
concentrated to 10mL under reduced pressure and then
benzene (40mL) was added. The benzene was removed
also under reduced pressure later. To the residue 200mL
dry pyridine was added and then stirred until dissolved.
The triphenylaminetetrazole (3.13g, 10mmol) in 100mL
13. Yang, J.-S.; Chiou, S.-Y.; Liau, K.-L. J. Am. Chem. Soc.
2002, 124, 2518–2527.